A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model

…, K Esaki, M Funaki, C Moriyama, E Tanaka… - Nature medicine, 2012 - nature.com
Hemophilia A is a bleeding disorder resulting from coagulation factor VIII (FVIII) deficiency.
Exogenously provided FVIII effectively reduces bleeding complications in patients with severe …

[HTML][HTML] Identification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activity

…, C Moriyama, T Wakabayashi, E Tanaka… - PloS one, 2013 - journals.plos.org
In hemophilia A, routine prophylaxis with exogenous factor VIII (FVIII) requires frequent
intravenous injections and can lead to the development of anti-FVIII alloantibodies (FVIII inhibitors…

[HTML][HTML] A review of clinical characteristics and genetic backgrounds in Alport syndrome

…, A Kobayashi, E Tanaka, K Tanaka… - Clinical and …, 2019 - Springer
Alport syndrome (AS) is a progressive hereditary renal disease that is characterized by
sensorineural hearing loss and ocular abnormalities. It is divided into three modes of inheritance, …

Reliability and validity of the Japanese version of the Temperament and Character Inventory

N Kijima, E Tanaka, N Suzuki, H Higuchi… - Psychological …, 2000 - journals.sagepub.com
The Temperament and Character Inventory was translated into Japanese, and, to confirm
the psychometric properties of the inventory, three samples were recruited from a nonpatient …

Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo

…, T Kozai, K Miyata, T Higo, E Tanaka… - Journal of the American …, 1998 - jacc.org
Objectives. This study was designed to examine whether or not intramural delivery of ST638
(a specific tyrosine kinase inhibitor) with biodegradable stent can suppress the restenotic …

Hopelessness in a community population: Factorial structure and psychosocial correlates

E Tanaka, S Sakamoto, Y Ono, S Fujihara… - The Journal of social …, 1998 - Taylor & Francis
… Address correspondence to Eriko Tanaka, c/o Z Kitamura, Department of Sociocultural
Environmental Research, National Institute of Mental Health, 1-7-3 Kohnodai, Ichikawa, Chiba …

[PDF][PDF] Exploitation of elevated extracellular ATP to specifically direct antibody to tumor microenvironment

…, T Sakashita, T Muraoka, K Aso, H Katada, E Tanaka… - Cell reports, 2020 - cell.com
The extracellular adenosine triphosphate (ATP) concentration is highly elevated in the tumor
microenvironment (TME) and remains tightly regulated in normal tissues. Using phage …

Mycophenolate mofetil after rituximab for childhood-onset complicated frequently-relapsing or steroid-dependent nephrotic syndrome

K Iijima, M Sako, M Oba, S Tanaka… - Journal of the …, 2022 - journals.lww.com
Background Rituximab is the standard therapy for childhood-onset complicated frequently
relapsing or steroid-dependent nephrotic syndrome (FRNS/SDNS). However, most patients …

Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: typical and atypical manifestations

R Ukisu, T Kushihashi, E Tanaka, M Baba, N Usui… - Radiographics, 2006 - pubs.rsna.org
Creutzfeldt-Jakob disease causes progressive dementia and, eventually, death. The infectious
agent is thought to be proteinaceous scrapie particles. Prompt diagnosis is essential to …

[HTML][HTML] Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome

…, T Okamoto, K Kamei, Y Kaku, R Fujimaru, R Tanaka… - Kidney international, 2020 - Elsevier
To understand the genetics of steroid-sensitive nephrotic syndrome (SSNS), we conducted
a genome-wide association study in 987 childhood SSNS patients and 3,206 healthy …